US Real-World Effectiveness Study of Nirmatrelvir/Ritonavir in Preventing Hospitalization of High-Risk COVID-19 Patients

US Real-World Effectiveness Study of Nirmatrelvir/Ritonavir in Preventing Hospitalization of High-Risk COVID-19 Patients

Purpose: We describe nirmatrelvir/ritonavir (NMV/r) effectiveness in preventing hospitalization among COVID-19 patients at high risk of severe disease. Methods: An ongoing US population-based observational cohort study with retrospective and prospective collection of national electronic healthcare d...

Full description

Saved in:
Bibliographic Details
Main Authors: Mark R. Cullen, MD, Xiaofeng Zhou, PhD, Scott P. Kelly, PhD, Caihua Liang, MD, PhD, Ling Li, MS, Rongjun Shen, MS, Heidi K. Leister-Tebbe, BSN, Steven G. Terra, PharmD, Michael Gaffney, PhD, Leo Russo, PhD
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Current Therapeutic Research
Subjects:
Antiviral
COVID-19
Nirmatrelvir/ritonavir
Real-world
SARS-CoV-2
Online Access:http://www.sciencedirect.com/science/article/pii/S0011393X24000274
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S0011393X24000274

Similar Items